State Of Wyoming Allakos Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$5.08 - $9.81 $2,819 - $5,444	-555 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$8.55 - $111.89 $701 - $9,174	82 Added 17.34%	555 $5,000
Q3 2021 Feb 11, 2022	SELL	$76.53 - $110.43 $25,025 - $36,110	-327 Reduced 40.88%	473 $50,000
Q2 2021 Feb 11, 2022	BUY	$85.37 - $114.1 $38,331 - $51,230	449 Added 127.92%	800 $68,000
Q1 2021 Feb 08, 2022	BUY	$109.73 - $153.66 $38,515 - $53,934	351 New	351 $40,000

68.8M

20.9K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $22M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.